Further advancing its popular endoscopic vessel harvesting technology for cardiac surgeons who are taking down veins for CABGs and other bypass grafts, MAQUET Cardiovascular has just introduced a new VASOVIEW HEMOPRO 2. According to the company, the minimally invasive system “utilizes next-generation HEMOPRO cut-and-seal technology to reduce thermal spread and to achieve optimal conduit quality for coronary artery bypass graft (CABG) surgery patients.”
The newly designed HEMOPRO 2 Jaws feature a unique insulated area, providing the main conduit maximum protection during side branch dissection. The HEMOPRO 2 Jaws also feature an enhanced edge for spot cautery to provide a clearer working tunnel and extended cutting capability to allow cutting even from within the innermost corner of the tool. These design changes improve the robustness of the EVH procedure and are easy for users to learn.
The VASOVIEW HEMOPRO 2 System can be used in conjunction with the new VASOSHIELD Pressure Controlling Syringe, also recently introduced by MAQUET Cardiovascular. For a harvested artery or vein, the VASOSHIELD Pressure Controlling Syringe helps prevent overdistension during vessel preparation steps, thus protecting endothelial integrity. Uncontrolled pressure with a standard syringe may cause overdistension of the vessel prior to surgery, which can injure the endothelial lining of the vessel, potentially affecting long term patency results.